Posters Presented in 2012

ASCO IST-CAR-516 Poster

A Phase 1/2 Study of Carfilzomib (CFZ) as a Replacement for Bortezomib (BTZ) for Multiple Myeloma (MM) Patients (pts) Progressing While Receiving a BTZ-Containing Combination Regimen

Download Results of this Study